Lv1
60 积分 2022-03-28 加入
Recent Advances in the Linkers of Drug Conjugates
1小时前
已完结
Antibody–oligonucleotide conjugates enter the clinic
3小时前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
1个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
1个月前
已完结
THERAPEUTIC OLIGONUCLEOTIDES, IMPURITIES, DEGRADANTS, AND THEIR CHARACTERIZATION BY MASS SPECTROMETRY
3个月前
已完结
Impurities in Oligonucleotide Drug Substances and Drug Products
3个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
3个月前
已完结
Phosphoramidite Platform for the Automated Synthesis of Morpholino Antisense Oligonucleotides and Their Chimeras
6个月前
已完结
Engineering considerations for next-generation oligonucleotide therapeutics
6个月前
已完结
Sustainable Approaches in Solid-phase Oligonucleotide Synthesis: Current Status and Future Directions
6个月前
已完结
皖公网安备34019202002308
